Neurogenic bladder
ICD-10 N31.9; N31.0; N31.0; N31.1; N31.2; N31.8 · ICD-11 GC01.4

Neurogenic Bladder with Urinary Retention: What to Do When Alpha-Blockers Do Not Achieve Adequate Bladder Emptying

In patients with neurogenic lower urinary tract dysfunction (NLUTD), urinary retention with elevated post-void residual urine volume and detrusor sphincter dyssynergia can persist despite first-line voiding management. When that management no longer achieves its goals, a structured next-step protocol applies.

Clinical scenario
This protocol applies to neurogenic bladder presenting with:
  • Urinary retention
  • Elevated post-void residual urine volume
  • Detrusor sphincter dyssynergia
Prior treatment — insufficient response
Alpha-blockers were used to improve voiding parameters in patients capable of spontaneous voiding. Escalation to this protocol is indicated when the targets of that first-line therapy — decreased post-void residual urine volume and increased voided volume — were not achieved.
Management approach
The protocol centres on a catheterisation-based strategy to facilitate bladder emptying, with guidance on which approach is preferred and under what circumstances an alternative may be indicated. Full details — including the preferred method and the specific conditions governing each option — are in the complete protocol below.
Instant Access to Structured Evidence-Based Regimens

References

Clinicians may recommend alpha-blockers to improve voiding parameters in NLUTD patients who spontaneously void.
Clinicians should recommend intermittent catheterization rather than indwelling catheters to facilitate bladder emptying in patients with NLUTD.
For appropriately selected NLUTD patients who require a chronic indwelling catheter, clinicians should recommend suprapubic catheterization over an indwelling urethral catheter.
View source ↗